Cargando…

Discharge destination and readmissions among patients with head and neck cancer

OBJECTIVE: Lowering hospital readmission rates is a national goal, and presents an opportunity to lower health care costs, improve quality, and increase patient satisfaction. We aim to assess whether discharge disposition is associated with readmission. METHODS: A retrospective cohort study using lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tucker, Jacqueline, Hollenbeak, Christopher S., Goyal, Neerav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575139/
https://www.ncbi.nlm.nih.gov/pubmed/36262465
http://dx.doi.org/10.1002/lio2.890
_version_ 1784811259097513984
author Tucker, Jacqueline
Hollenbeak, Christopher S.
Goyal, Neerav
author_facet Tucker, Jacqueline
Hollenbeak, Christopher S.
Goyal, Neerav
author_sort Tucker, Jacqueline
collection PubMed
description OBJECTIVE: Lowering hospital readmission rates is a national goal, and presents an opportunity to lower health care costs, improve quality, and increase patient satisfaction. We aim to assess whether discharge disposition is associated with readmission. METHODS: A retrospective cohort study using logistic regression to quantify risk factors of hospital readmission in patients with confirmed head and neck cancer (HNC) who underwent surgery from 2010 to 2018 contained in the Pennsylvania Health Care Cost Containment Council database, which includes patients treated in Pennsylvania hospitals. RESULTS: The readmission rate in this study was 18.1%. Cancers of the hypopharynx had the highest rates of readmission (29.2%). Male sex (odds ratio [OR]: 0.87, 95% CI: 0.75–1.00), emergent admission (vs. elective admission: OR = 1.33, 95% CI: 1.02–1.74), discharge to home health (vs. home: OR = 1.85, 95% CI: 1.59–2.16), discharge to skilled nursing facility (SNF) (vs. home: OR = 2.21, 95% CI: 1.80–2.72), and having 4+ comorbidities (vs. 0–1: OR = 1.39, 95% CI: 1.09–1.76) were significant risk factors for hospital readmission. CONCLUSION: It is necessary to consider the readmission risk associated with HNC patients. Reasons for readmission are multifactorial and can be related to demographics, hospital course, comorbidities, or discharge disposition–this requires further assessment. There is importance in increasing HNC awareness and staff education about the unique needs of this population. LEVEL OF EVIDENCE: 4.
format Online
Article
Text
id pubmed-9575139
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-95751392022-10-18 Discharge destination and readmissions among patients with head and neck cancer Tucker, Jacqueline Hollenbeak, Christopher S. Goyal, Neerav Laryngoscope Investig Otolaryngol Head and Neck, and Tumor Biology OBJECTIVE: Lowering hospital readmission rates is a national goal, and presents an opportunity to lower health care costs, improve quality, and increase patient satisfaction. We aim to assess whether discharge disposition is associated with readmission. METHODS: A retrospective cohort study using logistic regression to quantify risk factors of hospital readmission in patients with confirmed head and neck cancer (HNC) who underwent surgery from 2010 to 2018 contained in the Pennsylvania Health Care Cost Containment Council database, which includes patients treated in Pennsylvania hospitals. RESULTS: The readmission rate in this study was 18.1%. Cancers of the hypopharynx had the highest rates of readmission (29.2%). Male sex (odds ratio [OR]: 0.87, 95% CI: 0.75–1.00), emergent admission (vs. elective admission: OR = 1.33, 95% CI: 1.02–1.74), discharge to home health (vs. home: OR = 1.85, 95% CI: 1.59–2.16), discharge to skilled nursing facility (SNF) (vs. home: OR = 2.21, 95% CI: 1.80–2.72), and having 4+ comorbidities (vs. 0–1: OR = 1.39, 95% CI: 1.09–1.76) were significant risk factors for hospital readmission. CONCLUSION: It is necessary to consider the readmission risk associated with HNC patients. Reasons for readmission are multifactorial and can be related to demographics, hospital course, comorbidities, or discharge disposition–this requires further assessment. There is importance in increasing HNC awareness and staff education about the unique needs of this population. LEVEL OF EVIDENCE: 4. John Wiley & Sons, Inc. 2022-08-18 /pmc/articles/PMC9575139/ /pubmed/36262465 http://dx.doi.org/10.1002/lio2.890 Text en © 2022 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Head and Neck, and Tumor Biology
Tucker, Jacqueline
Hollenbeak, Christopher S.
Goyal, Neerav
Discharge destination and readmissions among patients with head and neck cancer
title Discharge destination and readmissions among patients with head and neck cancer
title_full Discharge destination and readmissions among patients with head and neck cancer
title_fullStr Discharge destination and readmissions among patients with head and neck cancer
title_full_unstemmed Discharge destination and readmissions among patients with head and neck cancer
title_short Discharge destination and readmissions among patients with head and neck cancer
title_sort discharge destination and readmissions among patients with head and neck cancer
topic Head and Neck, and Tumor Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575139/
https://www.ncbi.nlm.nih.gov/pubmed/36262465
http://dx.doi.org/10.1002/lio2.890
work_keys_str_mv AT tuckerjacqueline dischargedestinationandreadmissionsamongpatientswithheadandneckcancer
AT hollenbeakchristophers dischargedestinationandreadmissionsamongpatientswithheadandneckcancer
AT goyalneerav dischargedestinationandreadmissionsamongpatientswithheadandneckcancer